Alembic Ltd. logo

Alembic Ltd. (ALEMBICLTD)

Market Closed
17 Jun, 22:00
MSE MSE
90. 87
+1.87
+2.1011%
- Market Cap
- P/E Ratio
9.6% Div Yield
27,558 Volume
- Eps
89
Previous Close
Add Transaction
Day Range
88.97 91.59
Year Range
70.64 125.7
Want to track ALEMBICLTD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALEMBICLTD closed Wednesday higher at ₹90.87, an increase of 2.1011% from Tuesday's close, completing a monthly decrease of -0.2525% or -₹0.23. Over the past 12 months, ALEMBICLTD stock lost -10.1187%.
ALEMBICLTD pays dividends to its shareholders, with the most recent payment made on Aug 14, 2025. The next estimated payment will be in In 1 month on Aug 14, 2026 for a total of ₹2.4.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 2.4485%, based on the last three reports.
Alembic Ltd. has completed 4 stock splits, with the recent split occurring on Sep 27, 2013.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

ALEMBICLTD Chart

Alembic Ltd. (ALEMBICLTD) FAQ

What is the stock price today?

The current price is ₹90.87.

On which exchange is it traded?

Alembic Ltd. is listed on MSE.

What is its stock symbol?

The ticker symbol is ALEMBICLTD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 9.6%.

What is its market cap?

As of today, no market cap data is available.

Has Alembic Ltd. ever had a stock split?

Alembic Ltd. had 4 splits and the recent split was on Sep 27, 2013.

Alembic Ltd. Profile

Real Estate Management & Development Industry
Real Estate Sector
Ms. Malika Chirayu Amin CEO
MSE Exchange
INE426A01027 ISIN
India Country
285 Employees
5 Aug 2025 Last Dividend
26 Sep 2006 Last Split
- IPO Date

Overview

Alembic Limited, established in 1907, is a renowned entity in the field of real estate, both domestically within India and on an international scale. The company has carved its niche through two primary segments: Active Pharmaceutical Ingredients (API) and Real Estate. Its operational headquarter is located in Vadodara, India, emphasizing its significant presence in the Indian market. Furthermore, Alembic Limited operates as a subsidiary under Nirayu Pvt. Ltd., reflecting its strategic business structure and affiliations. Over the years, the company has diversified its portfolio to include project management, marketing consultancy services, and the leasing of commercial properties, alongside its traditional real estate construction and pharmaceutical production activities. This blend of services underscores the company's adaptability and its comprehensive approach to catering to a wide array of customer needs, from individual clients to corporate entities and business houses.

Products and Services

  • Real Estate Development

    Alembic Limited is actively involved in constructing a wide range of residential and commercial real estate projects. The company takes a holistic approach to development, ensuring high standards of quality and innovation across all its endeavors. This segment underscores the company’s commitment to contributing to the architectural skyline, whether through luxury living spaces or functional commercial properties.

  • Project Management and Marketing Consultancy Services

    To complement its construction activities, Alembic Limited offers specialized project management and marketing consultancy services. These services are designed to assist clients in navigating the complexities of real estate development, from ideation to completion and sale. By leveraging industry insights and marketing strategies, the company aims to enhance the viability and success of projects.

  • Leasing of Commercial Properties

    Alembic Limited has also ventured into the leasing of commercial properties, providing flexible and strategic real estate solutions for businesses of all sizes. This service allows companies to operate within Alembic’s high-quality premises, benefiting from prime locations and state-of-the-art facilities.

  • Active Pharmaceutical Ingredients (API)

    The manufacture and marketing of fermentation and chemistry-based APIs represent a crucial segment of Alembic Limited's operations. Serving the pharmaceutical industry, the company's API production is supported by extensive research and development efforts, aiming to deliver high-quality and effective ingredients for a wide range of medical applications.

  • Power Generation

    Alembic Limited demonstrates its commitment to sustainability and innovation through its involvement in power generation. Utilizing co-generation plants and wind power sources, the company not only supports its own energy requirements but also contributes to the broader aim of promoting renewable energy sources.

Contact Information

Address: Alembic Road
Phone: 91 26 5663 7300